- Full Year 2023 Sulzer AG Earnings Call TranscriptFeb 22, 2024CHF95.6 (+8.73%)Earnings
- Half Year 2023 Sulzer AG Earnings Call TranscriptJul 25, 2023CHF84.25 (+3.63%)Earnings
- Full Year 2022 Sulzer AG Earnings Call TranscriptFeb 20, 2023Earnings
- Q3 2022 Sulzer AG Order Report Call TranscriptOct 26, 2022
- Half Year 2022 Sulzer AG Earnings Call TranscriptJul 29, 2022Earnings
- Sulzer AG Annual Shareholders Meeting TranscriptApr 06, 2022
- Q1 2022 Sulzer AG Order Intake Call TranscriptApr 06, 2022
- Full Year 2021 Sulzer AG Earnings Call TranscriptFeb 18, 2022Earnings
- Sulzer AG to Discuss Succession Plan Call TranscriptDec 06, 2021
- Q3 2021 Sulzer AG Order Intake Call TranscriptOct 27, 2021
- Half Year 2021 Sulzer AG Earnings Call TranscriptJul 22, 2021Earnings
- Sulzer AG Virtual Capital Markets Day TranscriptJun 15, 2021
- Sulzer AG to Spin-Off Applicator Systems To Be Renamed Medmix Call TranscriptMay 27, 2021
- Sulzer AG Annual Shareholders Meeting TranscriptApr 14, 2021
- Full Year 2020 Sulzer AG Earnings Call TranscriptFeb 24, 2021Earnings
- Q3 2020 Sulzer AG Order Intake Call TranscriptOct 29, 2020
- Half Year 2020 Sulzer AG Earnings Call TranscriptJul 24, 2020Earnings
- Q1 2020 Sulzer AG Order Intake Call TranscriptApr 21, 2020
- Full Year 2019 Sulzer AG Earnings Call TranscriptFeb 19, 2020Earnings
- Q3 2019 Sulzer AG Order Intake Call TranscriptOct 23, 2019
- Half Year 2019 Sulzer AG Earnings Call TranscriptJul 24, 2019Earnings
Q3 2021 Sulzer AG Order Intake Call Transcript
Ladies and gentlemen, welcome to the Sulzer Q3 2021 Order Intake Conference Call and Live Webcast. I am Paolo, the Chorus Call operator. The conference must not be recorded for publication or broadcast. At this time, it's my pleasure to hand over to Christoph Ladner, Head of Investor Relations. Please go ahead, sir.
Thank you, Paolo, and good morning, and welcome to Sulzer's Q3 conference call. Today with me is our CEO, Grég Poux-Guillaume; and our CFO, Jill Lee. For this call, we have prepared a presentation, which you can find on our home page. As always, I want to draw your attention on the disclaimer on Slide #2. Please read it through carefully.
Before I hand over to Grég, let me say a couple of words on the treatment of Medmix on Slide #3. The spin-off of Applicator Systems was concluded at the end of Q3. Our shareholders approved the split on the extraordinary shareholder meeting on September 20. And Medmix, as it is now known, was traded for the first time as a separate company at the SIX Swiss
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)